Cargando…

Status of Remdesivir: Not Yet Beyond Question!

Detalles Bibliográficos
Autor principal:	Chatterjee, Saptarshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IMSS. Published by Elsevier Inc. 2021
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505045/ https://www.ncbi.nlm.nih.gov/pubmed/32972773 http://dx.doi.org/10.1016/j.arcmed.2020.09.004

Ejemplares similares

Response to: Status of Remdesivir: Not Yet Beyond Question!
por: Saha, Abinit, et al.
Publicado: (2021)

Remdesivir in Breastfeeding
por: Sadati, Elham, et al.
Publicado: (2022)

Anaphylaxis Due to Remdesivir
por: Hopkins, Brian J., et al.
Publicado: (2021)

Remdesivir and COVID-19
por: Ferrara, Francesco, et al.
Publicado: (2020)

Digital psychopathology: a not yet explored frontier in mental status examination
por: Rocha, Helio G., et al.
Publicado: (2022)

Successful management of remdesivir extravasation
por: Conde-Estévez, David, et al.
Publicado: (2022)

Does Liver Resection Provide Long-Term Survival Benefits for Breast Cancer Patients with Liver Metastasis? A Question Yet to Be Answered
por: Lee, Ser Yee, et al.
Publicado: (2015)

Ethical communication to patient & society: a critical responsibility in COVID-19 pandemic
por: Chatterjee, Saptarshi
Publicado: (2020)

Remdesivir for COVID-19: Why Not Dose Higher?
por: Yan, Victoria C., et al.
Publicado: (2021)

Pulmonary administration of remdesivir in the treatment of COVID-19
por: Rasmussen, Henrik Berg, et al.
Publicado: (2020)

Bradycardia due to remdesivir: Report of two cases()
por: Cebrián Lara, Laura, et al.
Publicado: (2022)

Remdesivir for the treatment of COVID-19: author's response
por: Lee, Todd C., et al.
Publicado: (2023)

Liver injury in remdesivir-treated COVID-19 patients
por: Zampino, Rosa, et al.
Publicado: (2020)

Remdesivir versus ritonavir/lopinavir in COVID-19 patients
por: Vitiello, Antonio, et al.
Publicado: (2020)

Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir
por: Nakaya, Aya, et al.
Publicado: (2022)

The impact of an antimicrobial stewardship program restriction on remdesivir prescribing
por: Zeitler, Kristen E., et al.
Publicado: (2022)

Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir
por: Nakaya, Aya, et al.
Publicado: (2023)

The Sommerlad pen: Yet another use
por: Ahmad, Zeeshan
Publicado: (2011)

Yet another modification of Guedel’s airway
por: Ahuja, Vanita, et al.
Publicado: (2011)

Yet another lost guide wire
por: Dubey, Prakash K., et al.
Publicado: (2020)

Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks?
por: Vitiello, Antonio, et al.
Publicado: (2021)

Remdesivir in moderate to severe COVID-19: A matter of time?
por: Bonazzetti, Cecilia, et al.
Publicado: (2021)

Indian perspective of remdesivir: A promising COVID-19 drug
por: Singh, Devendra, et al.
Publicado: (2020)

Re: Remdesivir for the treatment of COVID-19 by Lee et al.
por: Beccacece, Alessia, et al.
Publicado: (2023)

Remdesivir modifies interferon response in hospitalized COVID-19 patients
por: Murphy, Sarah L., et al.
Publicado: (2022)

Endocrine disruptors: Ubiquitous, yet less known
por: Gude, Dilip
Publicado: (2011)

Mallampati class ‘zero’ - yet another cause?
por: Indira, G
Publicado: (2011)

Yet another pulmonary manifestation of tuberous sclerosis
por: Bhawna, Satija, et al.
Publicado: (2014)

Focusing on rare diseases in China: are we there yet?
por: Yang, Li, et al.
Publicado: (2015)

Massive pericardial effusion, yet no signs of tamponade!
por: Vaidyanathan, Sunitha, et al.
Publicado: (2017)

Reversible Kallmann Syndrome: Rare Yet Real
por: Soumya, Sudarsanababu Lalitha, et al.
Publicado: (2019)

Exploring intersectionality: an international yet individual issue
por: Alani, Zainab
Publicado: (2022)

Single-Cell RNA Sequencing Supports Preferential Bioactivation of Remdesivir in the Liver
por: Yan, Victoria C., et al.
Publicado: (2021)

Does Remdesivir maintain the race in the general treatment protocol of COVID-19?
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2021)

Reply to Yan and Muller, “Remdesivir for COVID-19: Why Not Dose Higher?”
por: Juneja, Kavita, et al.
Publicado: (2021)

Is it ‘Time to Think’ yet? Learning hubs in specialty training
por: Abdel Aziz, Muna Ibrahim, et al.
Publicado: (2021)

Esophageal Disorders Not Yet Addressed by High-resolution Manometry
por: Nicodème, Frédéric, et al.
Publicado: (2013)

Yet another cause for difficult extubation of nasotracheal tube
por: Annie, Sheeba J, et al.
Publicado: (2017)

COVID-19 and air pollution: the worst is yet to come
por: Dutheil, Frédéric, et al.
Publicado: (2020)

Quantification of Esophageal Angulation in Sigmoid Achalasia: Are We There Yet?
por: Nabi, Zaheer, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vlgn600sp0dem507l93t01h16r